Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3
Top Cited Papers
- 5 May 2011
- journal article
- review article
- Published by American Society of Hematology in Blood
- Vol. 117 (18), 4701-4705
- https://doi.org/10.1182/blood-2010-10-299529
Abstract
A panel of members of the 2009 International Myeloma Workshop developed guidelines for standard investigative workup of patients with suspected multiple myeloma. Both serum and urine should be assessed for monoclonal protein. Measurement of monoclonal protein both by densitometer tracing and/by nephelometric quantitation is recommended, and immunofixation is required for confirmation. The serum-free light chain assay is recommended in all newly diagnosed patients with plasma cell dyscrasias. Bone marrow aspiration and/or biopsy along with demonstration of clonality of plasma cells are necessary. Serum β2-microglobulin, albumin, and lactate dehydrogenase are necessary for prognostic purposes. Standard metaphase cytogenetics and fluorescent in situ hybridization for 17p, t(4;14), and t(14;16) are recommended. The skeletal survey remains the standard method for imaging screening, but magnetic resonance imaging frequently provides valuable diagnostic and prognostic information. Most of these tests are repeated during follow-up or at relapse.Keywords
This publication has 31 references indexed in Scilit:
- F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myelomaBlood, 2009
- International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disordersLeukemia, 2008
- Criteria for diagnosis, staging, risk stratification and response assessment of multiple myelomaLeukemia, 2008
- Clinical Impact of Discordance in Serum Albumin Measurements on Myeloma International Staging SystemJournal of Clinical Oncology, 2008
- FDG-positron-emission tomography for staging and therapeutic assessment in patients with plasmacytomaHaematologica, 2008
- Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myelomaBlood, 2008
- Comparison of Bromcresol Green and Agarose Protein Electrophoresis for Quantitation of Serum Albumin in Multiple MyelomaClinical Chemistry, 2007
- Immunoglobulin free light chains and solitary plasmacytoma of boneBlood, 2006
- Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significanceBlood, 2005
- International Staging System for Multiple MyelomaJournal of Clinical Oncology, 2005